Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance

(2010) Martha T. van der Beek et al.   TRANSPLANTATION

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

(2010) Camille N. Kotton et al.   TRANSPLANTATION

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

(2009) A. Åsberg et al.   AMERICAN JOURNAL OF TRANSPLANTATION

How we treat cytomegalovirus in hematopoietic cell transplant recipients

(2009) M. Boeckh et al.   BLOOD

Valganciclovir in Adult Solid Organ Transplant Recipients

(2009) Nancy Perrottet et al.   CLINICAL PHARMACOKINETICS

Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus

(2009) T. Allice et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR

(2008) Nathalie Schnepf et al.   ANTIVIRAL RESEARCH

Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection

(2008) David Boutolleau et al.   ANTIVIRAL RESEARCH

Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir

(2008) Sunwen Chou   REVIEWS IN MEDICAL VIROLOGY